Journal of Nuclear Cardiology

, Volume 15, Issue 6, pp 745–753

Independent and incremental prognostic value of left ventricular ejection fraction determined by stress gated rubidium 82 PET imaging in patients with known or suspected coronary artery disease

  • Kirkeith Lertsburapa
  • Alan W. Ahlberg
  • Timothy M. Bateman
  • Deborah Katten
  • Lyndy Volker
  • S. James Cullom
  • Gary V. Heller
Original Articles

Abstract

Background. Whether left ventricular ejection fraction (EF) obtained by gated rubidium 82 positron emission tomography (PET) myocardial imaging can identify patients at risk for future cardiac events is unclear.

Methods and Results. Consecutive patients with known or suspected coronary artery disease who underwent dipyridamole stress gated Rb-82 PET imaging were evaluated. Scoring of perfusion was accomplished by use of a 17-segment model. EF was automatically generated. Patients were stratified based on summed stress scores (SSSs) (0–3, 4–8, or >8) and stress EF (>50%, 40%–49%, or <40%). All-cause mortality was determined by use of the Social Security Death Index. Of 1,441 patients, 132 (9.2%) died during mean follow-up of 2.7±0.8 years. Annualized mortality rates across SSS groups were 2.4% for SSS of 0 to 3, 4.1% for SSS of 4 to 8, and 6.9% for SSS greater than 8 (P<.001). Similarly, annualized mortality rates were 2.4%, 6.2%, and 9.2% for the group with EF greater than 50%, group with EF of 40% to 49%, and group with EF lower than 40%, respectively (P<.001). On multivariate analysis, the addition of EF to clinical and perfusion variables significantly increased the globalX2 (73.3 to 107.7,P<.001). Integration of EF with SSS significantly enhanced risk stratification.

Conclusion. EF assessed by stress gated Rb-82 PET imaging provides independent and incremental prognostic information and, hence, should be routinely incorporated in risk assessment.

Key Words

Rubidium radioisotopes radionuclide imaging positron emission tomography exercise test vasodilator agents coronary arteriosclerosis left ventricular function prognosis risk assessment 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© American Society of Nuclear Cardiology 2003

Authors and Affiliations

  • Kirkeith Lertsburapa
    • 1
  • Alan W. Ahlberg
    • 1
  • Timothy M. Bateman
    • 2
    • 3
    • 4
  • Deborah Katten
    • 1
  • Lyndy Volker
    • 3
  • S. James Cullom
    • 3
  • Gary V. Heller
    • 1
  1. 1.the Nuclear Cardiology Laboratory, Henry Low Heart Center, Division of CardiologyHartford HospitalHartford
  2. 2.Cardiovascular ConsultantsKansas City
  3. 3.Cardiovascular Imaging TechnologiesKansas City
  4. 4.Mid America Heart InstituteKansas City
  5. 5.Nuclear Cardiology LaboratoryHartford HospitalHartford

Personalised recommendations